StarZero All shows Try the podcast clipper →

Rajiv Juneja

9 statements across 1 episodes · 5 bullish · 1 bearish · 1 people on the record · first statement Jun 17, 2026 by Rajiv Juneja · across every show →

On the record as a speaker too: Rajiv Juneja's record, appearances and statements → this page counts the times other people say the name.

Everything said about Rajiv Juneja, oldest first

Jun 17, 2026
Assertion Not checkable as stated
Juneja: 1984 Meerut pharma venture started with ₹69,000 outperformed Glaxo locally
“One time that company start, which was started with 69,000 rupees in 84, became Merit's number one company. We had written Blaxos, Cibla, any company, everybody. Every company.”
Rajiv Juneja Jun 17, 2026 ▶ 7:55 Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? · Nikhil Kamath
Jun 17, 2026 positive
Disclosure
Juneja: Mankind Pharma spends 2.75% of revenue on R&D, planning annual increases
“See, a company like us, we spend 2.75% on R&D. And what we've decided now, every year, we're supposed to increase it by 5.5%.”
Rajiv Juneja Jun 17, 2026 ▶ 2:31:16 Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? · Nikhil Kamath
Jun 17, 2026
Assertion Supported
Juneja: Indian pharmaceutical companies manufacture up to 50% of US medications
“That 40, 50% price that you buy over there are manufactured here. Indian companies.”
Rajiv Juneja Jun 17, 2026 ▶ 29:33 Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? · Nikhil Kamath
Jun 17, 2026 bullish
Assertion Partly supported
Juneja: Online sales of condoms in India are growing at 60% annually
“And if you just look at this right now, there is approximately, 50, 60% growth of condom sales online.”
Rajiv Juneja Jun 17, 2026 ▶ 1:38:40 Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? · Nikhil Kamath
Jun 17, 2026
Assertion Not publicly verifiable
Juneja: Only 20% of Indian doctors are affiliated with hospital chains
“So I feel today approximately 15, 20% doctors would be attached with hospitals.”
Rajiv Juneja Jun 17, 2026 ▶ 52:04 Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? · Nikhil Kamath
Jun 17, 2026 bullish
Prediction Open · timeframe Jun 2029
Juneja: GLP-1 adoption will drive increased sales of protein and nutritional supplements
“What we basically imagine, going forward, the sales of protein products, different kind of proteins, supplements, protein supplements, vitamins, minerals, other enzymes, cocaine, all sort of things, they will further increase.”
Rajiv Juneja Jun 17, 2026 ▶ 2:16:37 Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? · Nikhil Kamath
Jun 17, 2026 bullish
Opinion
Juneja: Prevention and immunity are the biggest commercial opportunities in Ayurveda
“Biggest in Ayurveda would be prevention side or immunity side.”
Rajiv Juneja Jun 17, 2026 ▶ 1:34:53 Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? · Nikhil Kamath
Jun 17, 2026 negative
Insight
Juneja: Ayurvedic doctors lose patients if they prescribe only slow-acting Ayurvedic remedies
“If a patient is coming to him, and if he prescribes only Ayurveda product, the patient will not come back to him. Because patient needs what? Instant relief. Faster relief.”
Rajiv Juneja Jun 17, 2026 ▶ 1:32:46 Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? · Nikhil Kamath
Jun 17, 2026 positive
Insight
Juneja: Pharma sales reps for unbranded companies must become personal brands
“So when you work in that kind of a company, ah, if you will not become a brand yourself, ah, company will not run.”
Rajiv Juneja Jun 17, 2026 ▶ 7:24 Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? · Nikhil Kamath
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 60 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more